Beyond weight reduction, the same trial reported several additional metabolic outcomes as secondary or exploratory endpoints: Improved glycaemic control reductions in HbA1c levels were observed in participants with type 2 diabetes in a separate Phase 2 cohort [3] [4] Reduced waist circumference suggesting a decrease in visceral (abdominal) fat, which is associated with cardiovascular risk Improvements in lipid profiles including reductions in triglycerides Potential signal for benefit in metabolic-associated steatotic liver disease (MASLD) based on the glucagon receptor's proposed role in hepatic fat metabolism
being found in liver, kidney, brain, lung, heart, pancreas, small intestine, prostate, spleen, and skeletal muscles (Hayes & Strange, 2000)
Cancer: Some cancers exploit glutathione metabolism to resist oxidative stress and chemotherapy, making it a target for cancer treatment strategies
Collagen & Elastin Synthesis Promotion A key factor in skin aging is the gradual loss of collagen and elastin, leading to sagging and fine lines